Healthy Volunteers

  • Home
  • Healthy Volunteers
Quantitative Mapping of Substantia Nigra Iron in Parkinson’s Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

Conditions:   Parkinson Disease;   REM Sleep Behavior Disorder;   Healthy
Intervention:   Drug: (11C)PE2I
Sponsors:   Weill Medical College of Cornell University;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 19, 2018 / by / in
Local and Widespread Hypoalgesic Effects of Neurodynamic Mobilization in Healthy Controls

Conditions:   Pain;   Pain, Neuropathic
Interventions:   Other: Neurodynamic Slider Mobilization;   Other: Neurodynamic Tensioner Mobilization;   Other: Sham Neurodynamic Mobilization
Sponsor:   Brenau University
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 18, 2018 / by / in
Variation in Urine Electrolytes, pH and Specific Gravity Throughout the Day

Condition:   Healthy
Interventions:   Dietary Supplement: Normal fluid intake without true lemon;   Dietary Supplement: Double fluid intake plus 3 bottles of water with True Lemon
Sponsors:   Adam Howe, MD;   Litholink
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 17, 2018 / by / in
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects

Condition:   Hypertension
Interventions:   Drug: Levamlodipine Malate Tablets;   Drug: Amlodipine Besylate Tablets
Sponsors:   Conjupro Biotherapeutics;   CSPC Ouyi Pharmaceutical Co., Ltd.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 14, 2018 / by / in
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

Conditions:   Vitamin D Insufficiency;   Secondary Hyperparathyroidism
Intervention:   Drug: CTAP101 Capsules
Sponsor:   OPKO Ireland Global Holdings Ltd.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 13, 2018 / by / in
Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users

Condition:   Healthy Recreational Drug Users
Interventions:   Drug: ACT-541468 50 mg;   Drug: Suvorexant 15 mg;   Drug: Zolpidem 10 mg;   Drug: Placebo
Sponsor:   Idorsia Pharmaceuticals Ltd.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

September 10, 2018 / by / in